Background: Niemann-Pick type C (NPC, MIM #257220) is a neuro-visceral disease, caused predominantly by pathogenic variants in the NPC1 gene. Here we studied patients with clinical diagnosis of NPC but inconclusive results regarding the molecular analysis.

Methods: We used a Next-Generation Sequencing (NGS)-panel followed by cDNA analysis. Latter, we used massively parallel single-cell RNA-seq (MARS-Seq) to address gene profiling changes and finally the effect of different variants on the protein and cellular levels.

Results: We identified novel variants and cDNA analysis allowed us to establish the functional effect of a silent variant, previously reported as a polymorphism. We demonstrated that this variant induces the skipping of exon 11 leading to a premature stop codon and identified it in NPC patients from two unrelated families. MARS-Seq analysis showed that a number of upregulated genes were related to the unfolded protein response (UPR) and endoplasmic reticulum (ER) stress in one specific patient. Also, for all analyzed variants, the NPC1 protein was partially retained in the ER.

Conclusion: We showed that the NPC1 silent polymorphism (p.V562V) is a disease-causing variant in NPC and that the UPR is upregulated in an NPC patient.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667330PMC
http://dx.doi.org/10.1002/mgg3.1451DOI Listing

Publication Analysis

Top Keywords

npc1 silent
8
silent variant
8
variant induces
8
induces skipping
8
skipping exon
8
unfolded protein
8
protein response
8
niemann-pick type
8
variants npc1
8
cdna analysis
8

Similar Publications

Background: Niemann-Pick type C (NPC, MIM #257220) is a neuro-visceral disease, caused predominantly by pathogenic variants in the NPC1 gene. Here we studied patients with clinical diagnosis of NPC but inconclusive results regarding the molecular analysis.

Methods: We used a Next-Generation Sequencing (NGS)-panel followed by cDNA analysis.

View Article and Find Full Text PDF

Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity.

Neurology

April 2020

From the Department of Neurology (T.B.-E., C.S., M.M., M.S., S.A.S.), German Center for Vertigo and Balance Disorders (T.B.-E., D.N., M.S.), and Institute of Radiology (D.A.C.), Ludwig Maximilians University, University Hospital Grosshadern, Munich, Germany; Departments of Neurology (T.B.-E.) and Nuclear Medicine (A.R.), Inselspital, University Hospital Bern, Switzerland; Department of Nuclear Medicine (M.B., A.R.), University Hospital, LMU Munich; Department of Neurology (B.M.), University Hospital, Schleswig-Holstein, Kiel Campus; Institute for Medical Genetics and Genomics (S.B.-W.), Tübingen, Germany; Center for Neurodegenerative Science (C. K.-R., J.B.), Van Andel Research Institute, Grand Rapids, MI; Munich Cluster for Systems Neurology (SyNergy) (A.R.), Munich, Germany; and University of Bern (A.R.), Switzerland.

Objective: To characterize subclinical abnormalities in asymptomatic heterozygote mutation carriers as markers of neurodegeneration.

Methods: Motor function, cognition, mood, sleep, and smell function were assessed in 20 first-degree heterozygous relatives of patients with Niemann-Pick disease type C (NPC) (13 male, age 52.7 ± 9.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!